DK2920196T3 - Binding af cysteinrester under anvendelse af cykliske disulfider - Google Patents

Binding af cysteinrester under anvendelse af cykliske disulfider Download PDF

Info

Publication number
DK2920196T3
DK2920196T3 DK13854478.8T DK13854478T DK2920196T3 DK 2920196 T3 DK2920196 T3 DK 2920196T3 DK 13854478 T DK13854478 T DK 13854478T DK 2920196 T3 DK2920196 T3 DK 2920196T3
Authority
DK
Denmark
Prior art keywords
binding
cystein residues
cyclic disulfides
disulfides
cyclic
Prior art date
Application number
DK13854478.8T
Other languages
English (en)
Inventor
Jeffrey N Agar
Joseph Salisbury
Original Assignee
Univ Brandeis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Brandeis filed Critical Univ Brandeis
Application granted granted Critical
Publication of DK2920196T3 publication Critical patent/DK2920196T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/095Sulfur, selenium, or tellurium compounds, e.g. thiols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K19/00Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0089Oxidoreductases (1.) acting on superoxide as acceptor (1.15)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y115/00Oxidoreductases acting on superoxide as acceptor (1.15)
    • C12Y115/01Oxidoreductases acting on superoxide as acceptor (1.15) with NAD or NADP as acceptor (1.15.1)
    • C12Y115/01001Superoxide dismutase (1.15.1.1)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Psychology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK13854478.8T 2012-11-15 2013-11-15 Binding af cysteinrester under anvendelse af cykliske disulfider DK2920196T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261726776P 2012-11-15 2012-11-15
PCT/US2013/070239 WO2014078623A2 (en) 2012-11-15 2013-11-15 Tethering cysteine residues using cyclic disulfides

Publications (1)

Publication Number Publication Date
DK2920196T3 true DK2920196T3 (da) 2021-06-14

Family

ID=50731827

Family Applications (1)

Application Number Title Priority Date Filing Date
DK13854478.8T DK2920196T3 (da) 2012-11-15 2013-11-15 Binding af cysteinrester under anvendelse af cykliske disulfider

Country Status (6)

Country Link
US (5) US9428589B2 (da)
EP (1) EP2920196B1 (da)
JP (2) JP6480340B2 (da)
CA (1) CA2891261C (da)
DK (1) DK2920196T3 (da)
WO (1) WO2014078623A2 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6480340B2 (ja) * 2012-11-15 2019-03-06 ブランデイズ ユニバーシティー 環状ジスルフィドを用いるシステイン残基のテザリング
EA201591049A1 (ru) 2012-11-30 2015-09-30 Новартис Аг Способы получения конъюгатов дисульфидсодержащих белков
ES2729643T3 (es) 2013-11-26 2019-11-05 Novartis Ag Métodos para la conjugación de oxima con polipéptidos modificados con cetona
CN105535983B (zh) * 2014-05-28 2018-04-24 博瑞生物医药(苏州)股份有限公司 一种侧链含双硫五元环功能基团的碳酸酯聚合物在制备药物控制释放载体中的应用
CN104004001B (zh) * 2014-05-28 2016-03-30 苏州大学 含双硫五元环功能基团的环状碳酸酯单体及其制备方法
US10711261B2 (en) 2015-08-18 2020-07-14 Brandeis University Tethering cysteine residues using cyclic disulfides
MA46205A (fr) 2016-09-08 2019-07-17 Sabila Biosciences Llc Composés 1,2-dithiolane utiles dans la neuroprotection, les maladies et les états auto-immuns et cancéreux
IT201600101413A1 (it) 2016-10-10 2018-04-10 Sofar Swiss S A Composizione liquida per uso nel trattamento del reflusso gastroesofageo
WO2019014311A1 (en) * 2017-07-11 2019-01-17 Northeastern University HETEROCYCLIC DITHIOL CLICK CHEMISTRY
CA3097104A1 (en) 2018-04-19 2019-10-24 Stichting Vu Protein macrocyclization
JP7512207B2 (ja) * 2018-05-24 2024-07-08 サーナオミクス インコーポレイテッド 核酸治療薬のための調節可能な共カップリングポリペプチドナノ粒子送達系の組成物および方法
WO2024177503A1 (en) * 2023-02-21 2024-08-29 Stichting Vu Stabilized native protein complexes conjugated with branched molecules

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2260128A1 (en) * 1996-07-05 1998-01-15 William G. Rice Anti-viral pharmaceutical compositions containing saturated 1,2-dithiaheterocyclic compounds and uses thereof
CZ96798A3 (cs) * 1997-04-02 1998-10-14 Sankyo Company Limited Deriváty dithiolanu, jejich příprava a jejich terapeutické účinky
WO2005075513A1 (ja) * 2004-02-04 2005-08-18 National Institute Of Advanced Industrial Science And Technology システイン残基が酸化されたdj-1誘導体
GB0619291D0 (en) 2006-09-29 2006-11-08 Ucb Sa Altered antibodies
JP5792715B2 (ja) 2009-06-02 2015-10-14 ブランデイス ユニヴァーシティー スーパーオキシドジスムターゼモノマーの架橋
PL2442647T3 (pl) 2009-06-15 2016-09-30 Związki ditiolowe, pochodne i ich zastosowania
JP6480340B2 (ja) 2012-11-15 2019-03-06 ブランデイズ ユニバーシティー 環状ジスルフィドを用いるシステイン残基のテザリング

Also Published As

Publication number Publication date
US9428589B2 (en) 2016-08-30
US20150284478A1 (en) 2015-10-08
CA2891261A1 (en) 2014-05-22
CA2891261C (en) 2023-04-04
EP2920196A4 (en) 2016-06-01
US11987827B2 (en) 2024-05-21
EP2920196B1 (en) 2021-03-31
US11254923B2 (en) 2022-02-22
US20220135961A1 (en) 2022-05-05
US9944919B2 (en) 2018-04-17
US20160333336A1 (en) 2016-11-17
US20200283753A1 (en) 2020-09-10
WO2014078623A2 (en) 2014-05-22
EP2920196A2 (en) 2015-09-23
WO2014078623A3 (en) 2014-07-10
JP2019104743A (ja) 2019-06-27
JP2015536346A (ja) 2015-12-21
US10689639B2 (en) 2020-06-23
US20180245063A1 (en) 2018-08-30
JP6480340B2 (ja) 2019-03-06

Similar Documents

Publication Publication Date Title
DK2920196T3 (da) Binding af cysteinrester under anvendelse af cykliske disulfider
DK2906696T4 (da) Fremgangsmåder til modulering af c9orf72-ekspression
BR112015005783A8 (pt) análogos de glucagon
DK2605335T3 (da) Tilslutningsklemme
BR112014015681A2 (pt) análogos de glucagon
DK3725778T3 (da) Formuleringer af enzalutamid
DK2771364T3 (da) Fremstilling af heterodimere proteiner
BR112015001451A2 (pt) análogos de glucagon
DK3225604T3 (da) Fremgangsmåde til fremstilling af flerlagsruder
DK3454346T3 (da) Anordning til cylotronfremstilling af technetium-99m
DK2806791T3 (da) Udledning af individuelle thoraxparametre for et individ
DK3461895T3 (da) Modulation af ube3a-ats-ekspression
BR112013024076A2 (pt) análogos de glucagon
DK2822568T3 (da) Anvendelser af caseinsammensætninger
DK2870252T3 (da) Fremgangsmåder ved anvendelse af patatin
DK2859099T3 (da) Svampe-beta-xylosidase-varianter
DK2916661T3 (da) Fremgangsmåde til opnåelse af bloom-hæmmende komponenter til konfektureprodukter
DK2872536T3 (da) Fremgangsmåde til ekstraktion af biomasse
DK2740750T3 (da) Polyurethanbaserede klæbemidler
DK2931842T3 (da) Omdannelse af triacylglyceridholdige olier
DK2888228T3 (da) Inhibitorer af CD40-TRAF6 interaktion
DK2732707T3 (da) Fremgangsmåde til fremstilling af en sammensætning indeholdende caseinomacropeptid
DK2838850T3 (da) Oprensning af titantetrachlorid
DK2809782T3 (da) Forbedret fremgangsmåde til fremstilling af makrokugler
CO6920305A2 (es) Heterociclilpiri(mi)dinilpirazol